Avalus Ultra Post-Approval Study (PAS)
NCT: NCT06506903 · ACTIVE_NOT_RECRUITING
NCT IDNCT06506903
StatusACTIVE_NOT_RECRUITING
Start Date2024-11-20
Completion2026-11
Brief Summary
The purpose of this study is to characterize the safety and effectiveness of the Medtronic Avalus Ultra aortic valve bioprosthesis in patients with aortic valve disease.
Frequently Asked Questions
What is Avalus Ultra Post-Approval Study (PAS)?
Avalus Ultra Post-Approval Study (PAS) is a clinical trial registered under NCT06506903. Current status: ACTIVE_NOT_RECRUITING.
What is the status of NCT06506903?
The current status of NCT06506903 (Avalus Ultra Post-Approval Study (PAS)) is: ACTIVE_NOT_RECRUITING.
When did Avalus Ultra Post-Approval Study (PAS) start?
Avalus Ultra Post-Approval Study (PAS) started on 2024-11-20.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.